Transmedics Group Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Transmedics Group Inc 's ROA in the second quarter of 2026?
Transmedics Group Inc achieved a return on average assets (ROA) of 12.5 % in its second quarter of 2026, this is above TMDX's average return on assets of -10.92%.
Transmedics Group Inc assets over the 12 months ending in its second quarter of 2026 are valued at $1,228 million

ROA fell compared to the first quarter of 2026, despite the net income growth of 125.8% from the first quarter of 2026.

However, within the Healthcare sector 77 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2026 from 256 to 329.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	64.44 %	71.32 %	32.87 %	20.43 %	17.39 %
Y / Y Net Income Change	-52.68 %	-71.52 %	1436.87 %	476.83 %	186.26 %
Net Income (TTM) in million	154	172	190	92	72
Return On Assets (TTM)	12.5 %	15.85 %	20.34 %	10.55 %	8.64 %
TMDX's Total Ranking	# 329	# 256	# 575	# 727	# 1003
Total Assets (TTM) in million	1,464	1,435	1,068	946	891
Seq. Total Assets Change	2.06 %	34.3 %	12.93 %	6.23 %	6.33 %
Seq. Net Income Change	125.8 %	-93.06 %	333.34 %	-30.33 %	35.92 %

TMDX's 5 Years Annual ROA >> Back to TMDX Management Effectiveness >> Compare TMDX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 19
Sector	# 78
Overall	# 466

Return On Assets Statistics
High	Average	Low
20.34 %	-10.92 %	-37.62 %
(Dec 31 2025)		(Jun 30 2022)

Financial Statements
Transmedics Group Inc 's Assets	$ 1,464 million	TMDX's Balance sheet
Transmedics Group Inc 's Income	$ 17 million	Quarterly TMDX's Income Statement
TMDX's Income by Division		See TMDX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	32.87 %	13.88 %	154.76 %	105.46 %	-11.27 %
Total Assets in million	1,068	804	706	277	135
Y / Y Net Income Change	436.58 %	-	-	-	-
Net Income in million	190	35	-25	-36	-44
Annual Return On Assets	17.81 %	4.41 %	-3.54 %	-13.07 %	-32.78 %

TMDX's 5 Years Annual ROA >> Back to TMDX Management Effectiveness >> Compare TMDX ROA to its Competitors

Comment on TMDX's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 17.81 % compared to prior year, due to annual net income growth of 436.58 % to $190.29 million, while value of Transmedics Group Inc 's overall assets grew just by 32.87 % to $1,068.37 million, compared to $1,068.37 a year before.

More Return On Assets Ratios
TMDX's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TMDX's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TMDX's Competitors
Subscribers only: Roa for Transmedics Group Inc 's Suppliers
Subscribers only: Return On Assets for TMDX's Customers

You may also want to know
TMDX's Roi	TMDX's Inventory Turnover Ratio	TMDX's Growth Rates	TMDX's Dividend Comparisons
	TMDX's Profitability Ratios	TMDX's Asset Turnover Ratio	TMDX's Dividend Growth
TMDX's Roe	TMDX's Valuation Ratios	TMDX's Financial Strength Ratios	TMDX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Ironwood Pharmaceuticals inc	34.34 %
Idexx Laboratories Inc	33.61 %
Tg Therapeutics Inc	33.59 %
Meiragtx Holdings Plc	29.37 %
Indivior Pharmaceuticals Inc	28.21 %
Qhslab Inc	27.12 %
Adma Biologics Inc	26.58 %
Mettler toledo International Inc	24.86 %
Medpace Holdings Inc	24.84 %
Caredx Inc	24.81 %
Acadia Pharmaceuticals Inc	24.38 %
Eli Lilly And Company	21.97 %
Innoviva Inc	21.64 %
Vaxart Inc	20.85 %
Zevra Therapeutics Inc	20.39 %
Iradimed Corporation	20.36 %
Protalix Biotherapeutics inc	20.09 %
Pro dex Inc	19.87 %
Electromed Inc	19.39 %
United Therapeutics Corporation	17.98 %
Resmed Inc	17.80 %
Krystal Biotech Inc	17.65 %
Chemed Corporation	17.52 %
Zoetis Inc	17.19 %
Vertex Pharmaceuticals Inc	16.88 %
Halozyme Therapeutics Inc	16.55 %
Alnylam Pharmaceuticals Inc	15.76 %
Intuitive Surgical Inc	15.63 %
Healthcare Services Group Inc	15.21 %
Inspire Medical Systems inc	15.21 %

Date modified: 2026-09-26T07:36:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.